Sun Pharmaceutical acquisition of Concert Pharmaceuticals
We advised Sun Pharmaceutical on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Toronto-Dominion Bank $100 million notes offering
The investment-grade notes are due 2028
Jinxin Fertility Group HK$1.17 billion top-up placement of shares
The shares are listed on the Hong Kong Stock Exchange
CaixaBank $1.25 billion notes offering under $5 billion U.S. MTN program
The senior non-preferred callable fixed-to-floating-rate notes are due 2029
Expro $151.8 million secondary offering
The shares are listed on the NYSE
Instant Brands drop-down structured financing transactions
We advised the borrower in connection with the transactions
Sunny Optical Technology $400 million sustainability-linked bonds offering
The 5.95% bonds are due 2026
China Resources Beer RMB12.3 billion acquisition of Jinsha Winery
We advised China Resources Beer on the acquisition of a controlling interest in Jinsha Winery
Emerson $7.6 billion proposal to acquire National Instruments
We are advising Emerson on the proposal
GHK sale of Hasa to Wind Point
We advised GHK Capital Partners on the transaction